# Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery

> **NCT03755531** · PHASE4 · COMPLETED · sponsor: **Al-Kindy College of Medicine** · enrollment: 300 (actual)

## Conditions studied

- Postpartum Hemorrhage (Primary)

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT03755531
- **Lead sponsor:** Al-Kindy College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-04
- **Primary completion:** 2018-06-10
- **Final completion:** 2018-08-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2018-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755531, "Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03755531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*